TABLE 1.
Items | C | DSS | Cecropin A | Genta | SEM |
OS | 522a | 439b | 501a | 472ab | 10 |
Shannon | 6.2073a | 5.2736b | 5.8118a | 5.8738a | 0.10 |
Simpson | 0.9691a | 0.9255b | 0.9605a | 0.9495ab | 0.05 |
Chao1 | 508.51a | 459.98b | 507.17a | 490.37ab | 10.89 |
ACE | 539.18a | 458.83c | 519.22a | 490.51b | 10.55 |
Control: the control group (n = 9); Gentamicin: the mice was pretreated by using 2.5% DSS for 5 days and then intraperitoneal inject 5 mg/kg body weight gentamicin (n = 8). Cecropin A: the mice were pretreated by using 2.5% DSS for 5 days and then received intraperitoneal injection of 15 mg/kg body weight cecropin A (n = 9). DSS: The mice treated by 2.5% DSS (n = 7). The control group and DSS group received intraperitoneal injection of saline. The data were shown as mean ± SEM and when significant main effects or interactive effects were observed, the means were compared using the least significant difference (LSD) method. P < 0.05 were taken to indicate statistical significance between groups. Means with different letters “a” (the groups with highest level), “b” (the middle level”) and “c” (the lowest level)” are significantly different. OS, observed species; ACE, abundance-based coverage estimator.